RU2010119919A - Кристаллические химиотерапевтические средства - Google Patents
Кристаллические химиотерапевтические средства Download PDFInfo
- Publication number
- RU2010119919A RU2010119919A RU2010119919/04A RU2010119919A RU2010119919A RU 2010119919 A RU2010119919 A RU 2010119919A RU 2010119919/04 A RU2010119919/04 A RU 2010119919/04A RU 2010119919 A RU2010119919 A RU 2010119919A RU 2010119919 A RU2010119919 A RU 2010119919A
- Authority
- RU
- Russia
- Prior art keywords
- crystal
- equal
- ray
- chemotherapeutic products
- approximately
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Кристаллическая форма 1 N-[4-(3-амино-1H-индазол-4-ил)фенил]-N'-(2-фтор-5-метилфенил)мочевины, которая при измерении при приблизительно 25ºC с длиной волны рентгеновского излучения, равной 1,54178 Å, характеризуется порошковой рентгенограммой, имеющей относительные 2θ величины, приблизительно равные 7,8º, 9,1º, 11,0º, 11,8º и 12,1º.
Claims (1)
- Кристаллическая форма 1 N-[4-(3-амино-1H-индазол-4-ил)фенил]-N'-(2-фтор-5-метилфенил)мочевины, которая при измерении при приблизительно 25ºC с длиной волны рентгеновского излучения, равной 1,54178 Å, характеризуется порошковой рентгенограммой, имеющей относительные 2θ величины, приблизительно равные 7,8º, 9,1º, 11,0º, 11,8º и 12,1º.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98125307P | 2007-10-19 | 2007-10-19 | |
| US60/981,253 | 2007-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2010119919A true RU2010119919A (ru) | 2011-11-27 |
Family
ID=40174807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010119919/04A RU2010119919A (ru) | 2007-10-19 | 2008-10-16 | Кристаллические химиотерапевтические средства |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7960564B2 (ru) |
| EP (1) | EP2195301A1 (ru) |
| JP (1) | JP2011500707A (ru) |
| KR (1) | KR20100085987A (ru) |
| CN (1) | CN101827824B (ru) |
| AU (1) | AU2008312533A1 (ru) |
| BR (1) | BRPI0818334A2 (ru) |
| CA (1) | CA2699354A1 (ru) |
| CO (1) | CO6280484A2 (ru) |
| CR (1) | CR11443A (ru) |
| DO (1) | DOP2010000112A (ru) |
| EC (1) | ECSP10010176A (ru) |
| GT (1) | GT201000100A (ru) |
| MX (1) | MX2010004290A (ru) |
| PA (1) | PA8800601A1 (ru) |
| RU (1) | RU2010119919A (ru) |
| UA (1) | UA99489C2 (ru) |
| WO (1) | WO2009052230A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140031769A1 (en) | 2010-11-19 | 2014-01-30 | Forsight Vision4, Inc. | Therapeutic agent formulations for implanted devices |
| EP2739252A4 (en) | 2011-08-05 | 2015-08-12 | Forsight Vision4 Inc | DISPOSAL OF SMALL MOLECULES THROUGH AN IMPLANTABLE THERAPEUTIC DEVICE |
| AU2014236455B2 (en) | 2013-03-14 | 2018-07-12 | Forsight Vision4, Inc. | Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant |
| CA2957548A1 (en) | 2014-08-08 | 2016-02-11 | Forsight Vision4, Inc. | Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0410745A (pt) * | 2003-05-22 | 2006-06-27 | Abbott Lab | inibidores de indazol, benzisoxazol e benzisotiazol quinase |
| US7297709B2 (en) * | 2003-05-22 | 2007-11-20 | Abbott Laboratories | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| DE102005033100B3 (de) * | 2005-07-15 | 2007-01-25 | Sanofi-Aventis Deutschland Gmbh | Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung |
| WO2007015569A1 (ja) * | 2005-08-01 | 2007-02-08 | Eisai R & D Management Co., Ltd. | 血管新生阻害物質の効果を予測する方法 |
| US9006240B2 (en) * | 2005-08-02 | 2015-04-14 | Eisai R&D Management Co., Ltd. | Method for assay on the effect of vascularization inhibitor |
| EP1959926A1 (en) | 2005-10-25 | 2008-08-27 | Abbott Laboratories | Formulation comprising a drug of low water solubility and method of use thereof |
| EP1962803A1 (en) * | 2005-12-23 | 2008-09-03 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| US20070173538A1 (en) * | 2005-12-23 | 2007-07-26 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| EP2089003A1 (en) * | 2006-11-09 | 2009-08-19 | Abbott GmbH & Co. KG | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
-
2008
- 2008-10-15 US US12/251,893 patent/US7960564B2/en not_active Expired - Fee Related
- 2008-10-16 EP EP08840532A patent/EP2195301A1/en not_active Withdrawn
- 2008-10-16 UA UAA201006027A patent/UA99489C2/ru unknown
- 2008-10-16 CA CA2699354A patent/CA2699354A1/en not_active Abandoned
- 2008-10-16 CN CN2008801119453A patent/CN101827824B/zh not_active Expired - Fee Related
- 2008-10-16 KR KR1020107010996A patent/KR20100085987A/ko not_active Withdrawn
- 2008-10-16 MX MX2010004290A patent/MX2010004290A/es active IP Right Grant
- 2008-10-16 WO PCT/US2008/080067 patent/WO2009052230A1/en not_active Ceased
- 2008-10-16 BR BRPI0818334A patent/BRPI0818334A2/pt not_active IP Right Cessation
- 2008-10-16 AU AU2008312533A patent/AU2008312533A1/en not_active Abandoned
- 2008-10-16 JP JP2010530093A patent/JP2011500707A/ja active Pending
- 2008-10-16 RU RU2010119919/04A patent/RU2010119919A/ru not_active Application Discontinuation
- 2008-10-17 PA PA20088800601A patent/PA8800601A1/es unknown
-
2010
- 2010-04-16 DO DO2010000112A patent/DOP2010000112A/es unknown
- 2010-04-16 GT GT201000100A patent/GT201000100A/es unknown
- 2010-04-27 CO CO10049268A patent/CO6280484A2/es not_active Application Discontinuation
- 2010-05-14 EC EC2010010176A patent/ECSP10010176A/es unknown
- 2010-05-19 CR CR11443A patent/CR11443A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7960564B2 (en) | 2011-06-14 |
| BRPI0818334A2 (pt) | 2017-05-16 |
| PA8800601A1 (es) | 2009-05-15 |
| AU2008312533A1 (en) | 2009-04-23 |
| EP2195301A1 (en) | 2010-06-16 |
| GT201000100A (es) | 2012-04-12 |
| CA2699354A1 (en) | 2009-04-23 |
| MX2010004290A (es) | 2010-04-30 |
| CR11443A (es) | 2010-09-27 |
| US20090124815A1 (en) | 2009-05-14 |
| JP2011500707A (ja) | 2011-01-06 |
| ECSP10010176A (es) | 2010-06-29 |
| CN101827824B (zh) | 2012-10-03 |
| WO2009052230A1 (en) | 2009-04-23 |
| DOP2010000112A (es) | 2010-07-15 |
| KR20100085987A (ko) | 2010-07-29 |
| UA99489C2 (en) | 2012-08-27 |
| CO6280484A2 (es) | 2011-05-20 |
| CN101827824A (zh) | 2010-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122893T1 (el) | Κρυσταλλοι | |
| GB0428514D0 (en) | Compounds | |
| EA201000562A1 (ru) | Производные n-(пиразол-3-ил)бензамида в качестве активаторов глюкокиназы | |
| MA33952B1 (fr) | Nouveau dérivé 3 -hydroxy- 5-arylisothiazole | |
| TR201820824T4 (tr) | IL-12, IL-23 ve/veya IFN-alfa'nın modülatörleri olarak faydalı amid ile sübstitüe edilmiş heterosiklik bileşikler. | |
| NO20093200L (no) | Tiazolidinderivater | |
| NO330968B1 (no) | Ny fremgangsmate for syntesen av (1S)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| EA200300107A1 (ru) | Кристаллические формы трет-бутиламиновой соли периндоприла | |
| GEP20146124B (en) | Novel ccr2 receptor antagonists and usage thereof | |
| CY1112780T1 (el) | Νεα σουλφονυλοπυρρολια ως αναστολεις της ηdac | |
| NO20082209L (no) | Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer | |
| RU2014137257A (ru) | Способ получения сульфилиминовых соединений | |
| MY163114A (en) | Cyclopentylacrylamide derivative | |
| RU2010119919A (ru) | Кристаллические химиотерапевтические средства | |
| MY159183A (en) | 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives | |
| NO20082118L (no) | Heterocykliske CETP-inhibitorer | |
| RU2010119920A (ru) | Кристаллические химиотерапевтические средства | |
| WO2011045265A3 (en) | Spirocyclic derivatives as histone deacetylase inhibitors | |
| WO2008153027A1 (ja) | ピロロキノリン誘導体およびその用途 | |
| TW200724539A (en) | Benzimidazole derivative and use thereof | |
| DOP2010000116A (es) | Productos quimioterapeuticos cristalinos | |
| AR063006A1 (es) | Modificacion cristalina de 4-{[(6-cloropiridin-3-il)metil](metil)amino}furan-2(5h)-ona | |
| RU2010119928A (ru) | Кристаллические химиотерапевтические средства на основе индазола | |
| BRPI0907732A2 (pt) | compostos orgânicos | |
| JP2008509185A5 (ru) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20130925 |